Evaluation of a Pre-surgical Virtual Reality Simulation for Breast Cancer Surgery Patients

Sponsor
University of Manitoba (Other)
Overall Status
Recruiting
CT.gov ID
NCT04544618
Collaborator
(none)
45
1
3
10
4.5

Study Details

Study Description

Brief Summary

This study will pilot test and explore the feasibility of a virtual reality simulation of the operating room environment to reduce preoperative anxiety/distress in breast cancer patients. Study objectives are to evaluate recruitment and data collection procedures, outcome measures, participant feedback on the virtual reality operating room intervention, inclusion of a control intervention and treatment as usual group, and effects of the active intervention on symptoms of preoperative anxiety/distress.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual reality operating room simulation
  • Device: Non-surgery-related virtual reality simulation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This study will employ a single-blind randomized design (1:1:1 randomization; stratified according to surgery type [with vs. without reconstruction] and whether or not neoadjuvant chemotherapy was received; stratification will designate equal proportions of participants with these characteristics across each of the three study groups).This study will employ a single-blind randomized design (1:1:1 randomization; stratified according to surgery type [with vs. without reconstruction] and whether or not neoadjuvant chemotherapy was received; stratification will designate equal proportions of participants with these characteristics across each of the three study groups).
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Preoperative Virtual Reality for Breast Cancer Surgery Patients: A Feasibility and Pilot Study
Actual Study Start Date :
Dec 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active intervention group

Participants will be exposed to a virtual reality simulation of the operating room environment for a minimum of ten minutes.

Device: Virtual reality operating room simulation
The virtual reality simulation will begin with the participant sitting on a hospital bed wearing the virtual reality headset and holding the controllers. Participants will be oriented to the environment and provided with an explanation of how to navigate through the simulation (for approximately 2 minutes). Next, participants will explore the virtual operating room for a minimum of 5 minutes, or longer if desired. Following the exploration period, the scripted portion of the simulation will be begin. Here, participants will be taken through the mock anesthetic induction process (the virtual anesthetist will speak to the patient and walk them through the steps and the virtual nurse will assist). The simulation ends after the virtual oxygen mask is placed over the participant's mouth and the screen darkens.

Placebo Comparator: Control intervention group

Participants will explore a non-surgery related virtual reality simulation, pre-programmed to the virtual reality headset for a minimum of ten minutes.

Device: Non-surgery-related virtual reality simulation
Participants will explore a non-surgery-related virtual reality simulation (e.g., Google Earth simulation) pre-programmed to the virtual reality headset.

No Intervention: Treatment as usual group

Participants will receive standard of care with no additional intervention aside from information received at their surgical oncology appointment and optional preoperative education classes (available to all patients).

Outcome Measures

Primary Outcome Measures

  1. Self-reported impressions of the virtual reality operating room simulation [Immediately after the intervention]

    Patient acceptability questionnaire with open and close-ended items assessing patients' impressions of the intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Over the age of 18

  • Can speak and read English

  • Has a breast cancer diagnosis

  • Scheduled/being scheduled to undergo breast cancer surgery under general anesthesia at the Health Sciences Centre (Winnipeg, MB)

Exclusion Criteria:
  • Those who do not meet any inclusion criteria

  • Those who are not competent to provide informed consent (e.g., due to cognitive impairment)

  • Those who are unable to participate in a virtual reality intervention (e.g., due to visual/auditory impairment)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Health Sciences Centre Winnipeg Manitoba Canada R3E 3N4

Sponsors and Collaborators

  • University of Manitoba

Investigators

  • Principal Investigator: Jordana Sommer, MA, University of Manitoba
  • Principal Investigator: RenĂ©e El-Gabalawy, PhD, University of Manitoba
  • Study Director: Kristin Reynolds, PhD, University of Manitoba
  • Study Director: Pamela Hebbard, MD, University of Manitoba
  • Study Director: Natalie Mota, PhD, University of Manitoba
  • Study Director: Alan Mutch, MD, University of Manitoba
  • Study Director: Thomas Mutter, MD, University of Manitoba
  • Study Director: Rakesh Arora, MD, University of Manitoba
  • Study Director: Jessica Maples-Keller, PhD, Emory University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jordana Sommer, Principal Investigator, University of Manitoba
ClinicalTrials.gov Identifier:
NCT04544618
Other Study ID Numbers:
  • HS23957 (H2020:247)
  • 322523 340300 2000
First Posted:
Sep 10, 2020
Last Update Posted:
Apr 7, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jordana Sommer, Principal Investigator, University of Manitoba
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 7, 2022